CAMBRIDGE, Mass., Sept. 30, 2013 /PRNewswire/ -- LabCentral, an innovative, shared laboratory space designed to be a catalyst for high-potential entrepreneurs and life-sciences startups, reached another milestone last week with the addition of Eppendorf North America as a major sponsor. Eppendorf North America is the U.S. subsidiary of the Hamburg/Germany-based maker of quality laboratory equipment. Slated for opening November 1, 2013, LabCentral will become the first flexible, affordable, fully equipped and resourced lab and office facility in the heart of the Cambridge Biotech Innovation Hub.
"We are excited to become partners of LabCentral and proud to support LabCentral's mission to advance the life sciences in this innovative cluster," said President and CEO of Eppendorf North America, Matin Khajooei. "Eppendorf has a long tradition of supporting scientists in their work with best-in-class products and support. LabCentral's model is unique and will change the way biotechnology companies are built in the future," he added.
LabCentral received a competitive $5 million capital grant from the Massachusetts Life Science Center in February 2013, Triumvirate Environmental and Johnson & Johnson Innovation became founding sponsors shortly thereafter, and Edwards Wildman Palmer, LLP joined in the platinum category. Gold sponsors include Novartis Institutes for Biomedical Research, Cushman & Wakefield, and Cooley, LLP. MIT Investment Management Co. is LabCentral's real estate partner. Additional LabCentral sponsors include Ambit Creative, Kendall Press, Silicon Valley Bank, Steady Vision, and Union Office Interiors.
Commenting on the addition of Eppendorf to its growing list of sponsors, LabCentral President and Executive Director Johannes Fruehauf, said, "It is great to find committed partners like Eppendorf who share our
Copyright©2012 PR Newswire.
All rights reserved